Literature DB >> 22111063

Vascular dementia.

Ae Young Lee1.   

Abstract

Cerebrovascular disease is the second leading cause of cognitive impairment in the elderly, either alone or in combination with Alzheimer's disease (AD). Vascular dementia (VaD) is heterogeneous in terms of both clinical phenotype and pathogenetic mechanisms. It may result from multiple cortical infarctions due to cerebral large vessel pathologies or to subcortical ischemic changes such as leukoaraiosis or lacunar infarction due to cerebral small artery disease. Clinical symptoms and signs vary depending on the location and size of the stroke lesion, and no single neuropsychological profile characteristic of VaD has been defined, although dysexecutive function is common. A slightly higher mortality rate and slower progression are reported in VaD compared with AD. VaD is potentially preventable by rigorous identification and treatment of cardiovascular disease risk factors, and modest symptomatic improvement with cholinesterase inhibitors has been reported.

Entities:  

Keywords:  Cerebrovascular disorders; Executive function; Vascular dementia

Year:  2011        PMID: 22111063      PMCID: PMC3214877          DOI: 10.4068/cmj.2011.47.2.66

Source DB:  PubMed          Journal:  Chonnam Med J        ISSN: 2233-7393


  33 in total

1.  Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study.

Authors:  C Ballard; M Sauter; P Scheltens; Y He; F Barkhof; E C W van Straaten; W M van der Flier; C Hsu; S Wu; R Lane
Journal:  Curr Med Res Opin       Date:  2008-07-31       Impact factor: 2.580

2.  Ambulatory blood pressure and the brain: a 5-year follow-up.

Authors:  Iris B Goldstein; George Bartzokis; Donald Guthrie; David Shapiro
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

3.  Incidence and etiology of dementia in a large elderly Italian population.

Authors:  G Ravaglia; P Forti; F Maioli; M Martelli; L Servadei; N Brunetti; E Dalmonte; M Bianchin; E Mariani
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

4.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

5.  Donepezil in vascular dementia: a randomized, placebo-controlled study.

Authors:  D Wilkinson; R Doody; R Helme; K Taubman; J Mintzer; A Kertesz; R D Pratt
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

6.  Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology.

Authors:  A Brun
Journal:  Dementia       Date:  1994 May-Aug

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Incidence and prevalence of dementia in the Cardiovascular Health Study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

Review 9.  Dementia and cerebrovascular disease.

Authors:  David S Knopman
Journal:  Mayo Clin Proc       Date:  2006-02       Impact factor: 7.616

10.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging.

Authors:  P Scheltens; F Barkhof; D Leys; E C Wolters; R Ravid; W Kamphorst
Journal:  Neurology       Date:  1995-05       Impact factor: 9.910

View more
  18 in total

Review 1.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

2.  A tetramethylpyrazine piperazine derivate CXC137 prevents cell injury in SH-SY5Y cells and improves memory dysfunction of rats with vascular Dementia.

Authors:  Hao Zhang; Rong Sun; Xin-Yong Liu; Xiao-Ming Shi; Wen-Fang Wang; Lu-Gang Yu; Xiu-Li Guo
Journal:  Neurochem Res       Date:  2013-12-20       Impact factor: 3.996

Review 3.  Models and mechanisms of vascular dementia.

Authors:  Poornima Venkat; Michael Chopp; Jieli Chen
Journal:  Exp Neurol       Date:  2015-05-15       Impact factor: 5.330

4.  The montreal cognitive assessment and mini-mental state examination visuoexecutive subtests in acute ischemic stroke patients and their correlations with demographic and clinical factors.

Authors:  Wei Wang; Fang-Ming Dong; Kai Shao; Shang-Zun Guo; Zhong-Min Zhao; Yi-Ming Yang; Ya-Xue Song; Jian-Hua Wang
Journal:  Acta Neurol Belg       Date:  2020-11-21       Impact factor: 2.396

Review 5.  The common dementias: a pictorial review.

Authors:  Pervinder Bhogal; Colin Mahoney; Sophie Graeme-Baker; Amit Roy; Sachit Shah; Francesco Fraioli; Peter Cowley; Hans Rolf Jäger
Journal:  Eur Radiol       Date:  2013-10-01       Impact factor: 5.315

6.  Analysis on correlation of white matter lesion and lacunar infarction with vascular cognitive impairment.

Authors:  Ting Yan; Jia-Rui Yu; Yun-Pei Zhang; Tao Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo.

Authors:  Daniela Ehrlich; Christian Humpel
Journal:  J Neurol Sci       Date:  2012-07-20       Impact factor: 3.181

8.  Protective effect of Daming capsule against chronic cerebral ischemia.

Authors:  Xiaodan Song; Wenliang Zhu; Ran An; Yamei Li; Zhimin Du
Journal:  BMC Complement Altern Med       Date:  2015-05-14       Impact factor: 3.659

9.  Preparing a persian version of kimberley indigenous cognitive assessment for assessing the cognitive problems of illiterate geriatric patients.

Authors:  Amrollah Ebrahimi; Maryam Poorbafrani; Victoria Omranifard; Said Samandari; Fariba Noori
Journal:  Adv Biomed Res       Date:  2015-01-06

Review 10.  Using structural and diffusion magnetic resonance imaging to differentiate the dementias.

Authors:  Sana Suri; Anya Topiwala; Clare E Mackay; Klaus P Ebmeier; Nicola Filippini
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.